On 2025-05-09, Kymera Therapeutics, Inc. (KYMR) announced earnings per share of $-0.82 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.92.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.89 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-09 | 2025-03-31 | $-0.92 | $-0.82 |
| 2025-02-27 | 2024-12-31 | $-0.76 | $-0.88 |
| 2024-10-31 | 2024-09-30 | $-0.83 | $-0.82 |
| 2024-08-07 | 2024-06-30 | $-0.69 | $-0.58 |
| 2024-05-02 | 2024-03-31 | $-0.73 | $-0.69 |
| 2024-02-22 | 2023-12-31 | $-0.44 | $-0.25 |
| 2023-11-02 | 2023-09-30 | $-0.73 | $-0.90 |
| 2023-08-03 | 2023-06-30 | $-0.70 | $-0.67 |
| 2023-05-04 | 2023-03-31 | $-0.69 | $-0.70 |
| 2023-02-23 | 2022-12-31 | $-0.57 | $-0.60 |
| 2022-11-03 | 2022-09-30 | $-0.70 | $-0.79 |
| 2022-08-09 | 2022-06-30 | $-0.68 | $-0.78 |
| 2022-05-03 | 2022-03-31 | $-0.67 | $-0.71 |
| 2022-02-24 | 2021-12-31 | $-0.36 | $-0.66 |
| 2021-11-10 | 2021-09-30 | $-0.34 | $-0.56 |
| 2021-08-06 | 2021-06-30 | $-0.21 | $-0.55 |
| 2021-05-06 | 2021-03-31 | $-0.17 | $-0.29 |
| 2021-03-11 | 2020-12-31 | $0.09 | $-0.29 |
| 2020-11-05 | 2020-09-30 | $1.35 | $-0.39 |